Dominick @domhellen

PhD - Emory GMB // Postdoc - MIT BE // CEO & Founder - HTMP Bio htmpbio.com San Diego, CA Joined March 2013

Tweets

3K
Followers

502
Following

492
Likes

17K

Anshul Kundaje @anshulkundaje

3 months ago

Excellent post by Rachel Thomas in the ways AI hype is outrunning reality in life sciences linkedin.com/feed/update/ur…

21 142 605 28K 241

View Details

Keiichi Ito @itok10918

6 months ago

Human assembloids recapitulate periportal liver tissue in vitro | Nature nature.com/articles/s4158…

0 7 26 4K 7

View Details

Keiichi Ito @itok10918

6 months ago

In vivo gene editing of human hematopoietic stem and progenitor cells using envelope-engineered virus-like particles | Nature Biotechnology nature.com/articles/s4158…

0 34 159 16K 90

View Details

If you work regularly with molecular data, but don't prep it yourself, highly recommend reading the user manual for a kit you interact with cover to cover. Every little step is there for a reason + will teach you interesting biology. Small deviations at the bench often perturb your chunk of data in subtle ways.

1 12 122 13K 82

View Details

Sasha Gusev @SashaGusevPosts

7 months ago

I wrote a little bit about the "missing heritability" question and several recent studies that have brought it to a close. A short 🧵

10 98 463 194K 531

View Details

Dominick @domhellen

7 months ago

@ScienceYael Or EBV

0 0 2 189 0

View Details

Hepatology Communications @HepCommJournal

12 months ago

🚨 Liver Biopsy remains a 🔑 tool in our 🧰 , so #GIHepFellowshipBootcamp is here to get you ready to understand: 💉Utility of biopsy across conditions❕ 💉Biopsy histologic characteristics❕ 💡The table below is GOLD 🏆 journals.lww.com/hepcomm/fullte…

1 71 158 21K 161

View Details

Dominick @domhellen

12 months ago

@mia_ivosmd Congrats!!!

0 0 0 56 0

View Details

Dominick @domhellen

12 months ago

@scott_wad_dell Congrats 🎉

0 0 1 96 0

View Details

Elliot Tapper @ebtapper

12 months ago

0.85 to 3.5 million Americans meet criteria for Resmetirom use journals.lww.com/hepcomm/fullte…

1 26 106 14K 32

View Details

Eric Topol @EricTopol

a year ago

The potential risk of age-related macular degeneration with GLP-1 drugs in people with diabetes jamanetwork.com/journals/jamao…

14 74 251 43K 102

View Details

Lior Pachter @lpachter

a year ago

As @emukamel and Yu point out, #methodsmatter. They are spot on here: nature.com/articles/s4158…

2 24 124 18K 77

View Details

X. Edward Guo 郭向东 @edguo84

a year ago

From River Xiang to Harvard, from Columbia to Today: Reflections at a Critical Moment Nearly 40 years ago, I came from China to the U.S. with $50 in my pocket. I was fortunate to pursue graduate studies through the Harvard-MIT Health Sciences and Technology program — one of the world’s most rigorous interdisciplinary tracks. Almost 30 years ago, I joined Columbia University, helped found its Department of Biomedical Engineering, and later served as its Chair. These institutions shaped me, and I remain deeply committed to their missions. Today, Harvard, Columbia, and many peer institutions face unprecedented challenges — not just in science or funding, but in public trust, politicization, and cultural division. Yet I believe, more than ever, in their resilience. We must confront difficult truths. Discrimination — whether antisemitism, anti-Asian hate, or bias of any kind — still exists, even within institutions meant to lead on equity. We must not look away. And yet, while universities strive to uphold their values, we are seeing troubling actions from the outside. One striking example: the federal government’s decision to cancel Harvard’s international visa sponsorship program. This move doesn’t just shut doors on global talent — it weakens America’s innovation ecosystem and undermines our leadership in the world. Let us be clear: meaningful reform must come from within. Universities thrive not by decree, but through open dialogue, reflection, and academic independence. We must protect that. Each day, discoveries at places like Harvard and Columbia change and save lives — from curing disease to developing next-gen technologies. Undermining these institutions is not reform; it is self-harm. No university is perfect. But the strength of academia lies in its ability to evolve under pressure and emerge stronger. I believe they will. Let us defend the spaces where knowledge is created. Because when universities fall, society falters. #HigherEducation #Harvard #Columbia #Innovation #GlobalTalent #AcademicFreedom #Leadership #STEM

2 18 125 14K 2

View Details

Dominick @domhellen

a year ago

@Zhiliang_Bai @MIT @MITdeptofBE @kochinstitute Congratulations 🎉

0 0 1 159 0

View Details

David R. Liu @davidrliu

a year ago

Today in @ScienceMagazine we report the development of a laboratory-evolved CRISPR-associated transposase (evoCAST) that supports therapeutically relevant levels of RNA-programmable gene insertion in human cells, a collaboration with @SternbergLab. 1/13 drive.google.com/file/d/1I-UbCR…

21 307 1K 133K 395

View Details

NIH @NIH

a year ago

Today, NIH announced a new initiative to expand innovative, human-based science while reducing the use of animals in research. This aligns with @US_FDA’s initiative to reduce testing in animals. bit.ly/4jYd4T2

53 238 865 410K 171

View Details

bioRxiv SysBio @biorxiv_sysbio

a year ago

Systems biology framework for rational design of operational conditions for in vitro / in vivo translation of microphysiological systems biorxiv.org/cgi/content/sh… #biorxiv_sysbio

0 1 1 200 0

View Details

Dominick @domhellen

a year ago

Thank you to Luca Fabris and Camilla Venturin for complementing and outlining BiliQML

AJP-Gastrointestinal and Liver Physiology @ajpgi

a year ago

🎧Take a listen to this editorial focus in podcast format! Got Guts: A Chance to Put Liver Biopsy Back to Its Former Glory? 🎙️ow.ly/1bjE50VhAyH 📃ow.ly/y0SP50VhAyF #Cholangiocyte #DuctularReaction #Cholangiopathies #LiverBiopsy #MachineLearning

0 3 6 959 0

0 0 2 215 0

View Details

AJP-Gastrointestinal and Liver Physiology @ajpgi

a year ago

0 3 6 959 0

View Details

Dr. Shana Adise @ShanaAdise

a year ago

PhD programs are pausing admissions to graduate school due to NIH indirect cost cuts. See the growing number of programs here: docs.google.com/spreadsheets/d… How is science supposed to advance with fewer trainees, less $ for research? This is devastating.